Essilor Stellest 2.0 lenses with HALT Max technology led to significantly slower axial elongation than standard Essilor Stellest lenses, according to a study published in Translational Vision Science & Technology.Essilor Stellest lenses slow myopia pro…
That’s right — organic chemistry.You thought you were done with orgo. Admit it, the first thing you did after reading the headline of this column was sprint to your safe spot. You were so traumatized by the mere mention of organic chemistry that you pu…
That’s right — organic chemistry.You thought you were done with orgo. Admit it, the first thing you did after reading the headline of this column was sprint to your safe spot. You were so traumatized by the mere mention of organic chemistry that you pu…
The European regulator has recommended marketing approval for Ranluspec and Gotenfia after studies confirm their safety, efficacy, and cost-effectiveness compared with reference drugs. Medscape News Europe
The European regulator has recommended marketing approval for Ranluspec and Gotenfia after studies confirm their safety, efficacy, and cost-effectiveness compared with reference drugs. Medscape News Europe
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aviceda Therapeutics (“the Company” or “Aviceda”), a clinical-stage biotechnology company developing innovative therapies for retinal diseases, today announced topline results from its SIGLEC Phase 2b study evaluating…